ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
4 announcements with these filters
Indrayani Biotech received approval from the Registrar of Companies to extend the deadline for its FY 2025-26 Annual General Meeting by two months, until November 30, 2026.
A quarterly shareholding pattern filing by Indrayani Biotech Ltd for the period ending June 30, 2026.
Indrayani Biotech reported a delay in submitting its FY26 audited financial results due to subsidiary consolidation and audit disruptions. The trading window remains closed for designated persons.
Indrayani Biotech Limited submitted its compliance certificate for the quarter ended March 31, 2026, as per SEBI regulations. The certificate from its RTA, MUFG Intime India, confirms that securities received for dematerialisation were processed and listed on the exchanges within prescribed timelines.